|

GPC2 CAR T cells Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since August 2026

Also known as: GPC2-directed CAR T cells

Pipeline

Phase 1: 1

Top Sponsors

  • Stanford University1

Indications

  • FOXR2-activated1
  • CNS Neuroblastoma1
  • Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS1
  • Pineoblastoma1
  • Embryonal Tumor With Multilayered Rosettes (ETMR)1

Palo Alto, California1 trial

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Lucile Packard Children's Hospital Stanford

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.